Hematology NewsNew Multiple Myeloma Staging Systems Outperform the StandardDecember 20, 2023Multiple Myeloma
Hematology NewsSickle Cell CRISPR Gene Therapy May Offer Patients ‘Functional Cure’December 19, 2023Bleeding DisordersGene Therapy
Oncology PracticeSurvival-Toxicity Trade-off With T-DM1 in HER+ Breast CancerDecember 18, 2023Breast CancerPatient & Survivor CarePractice Management
Oncology PracticePregnancy safe after BRCA-mutated breast cancerDecember 18, 2023Breast CancerPatient & Survivor Care
Hematology NewsIn Transplant-Ineligible Myeloma, This Frontline Tx Is BetterDecember 15, 2023Multiple MyelomaTransplant
Hematology NewsNo Benefit to Salvage Transplant in R/R Multiple MyelomaDecember 14, 2023Multiple MyelomaTransplant
Oncology PracticePatients with HR-positive breast cancer can safely use ARTDecember 14, 2023Breast CancerMixed TopicsPatient & Survivor Care
Oncology PracticeLess is more for axillary surgery in early breast cancerDecember 14, 2023Breast CancerPatient & Survivor Care
Oncology PracticeFew with inflammatory breast cancer get guideline-based careDecember 14, 2023Breast CancerPatient & Survivor CarePractice Management
Hematology NewsSCD mortality rates improved for Black patients in 2010sDecember 13, 2023Bleeding DisordersAnemia
Hematology NewsMRD status predicts transplant benefit in NPM1-mutated AMLDecember 13, 2023AMLTransplant
Hematology NewsSickle Cell: Good Outcomes for Haploidentical TransplantsDecember 12, 2023Bleeding DisordersAnemiaTransplant
Hematology NewsMantle Cell Lymphoma: Drug Combo Improves PFSDecember 12, 2023Mantle Cell LymphomaAggressive LymphomasNon-Hodgkin Lymphoma
Oncology Practice‘Baby TAM’ effective, tolerable for breast cancer preventionDecember 12, 2023Breast CancerPractice ManagementPatient & Survivor Care
